The expression of proliferating cell nuclear antigen (PCNA) and of nucleolar organizer regions (AgNORs) correlates with the morphological type of bone marrow plasma cells in multiple myeloma (MM)

Polskie Archiwum Medycyny Wewnetrznej

Volumn 109, Issue 3, 2003, Pages 257-263

  Usnarska Zubkiewicz, Lidia ^a,d   Maryniak, Renata ^b   Podolak Dawidziak, Maria ^a   Wozniak, Zdzisław ^a   Jeleń, Michał ^c   Ramlau, Rodryg ^a   Porȩba, Małgorzata ^a   Kuliczkowski, Kazimierz ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

^c Oncology Department   (Poland)

^d Katedra i Klinika Hematologii   (Poland)

Author keywords

AgNORs; Multiple myeloma; PCNA

Indexed keywords

CHROMOSOME PROTEIN; CYCLINE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY PC 10; PROTEIN AGNOR; SILVER NITRATE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BLOOD VISCOSITY; BONE MARROW BIOPSY; BONE MARROW CELL; CELL NUCLEUS; CELL PROLIFERATION; CELL STRUCTURE; CHROMOSOME NOR; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY FAILURE; MALE; MULTIPLE MYELOMA; PROTEIN LOCALIZATION;

EID: 0037266446     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Barlogie B., Alexanian R., Gehan E.A.: Marrow cytometry and prognosis in myeloma. J. Clin. Invest., 1983, 72, 853.
2. Peest D., Coldewey R., Deicher H. et al.: Prognostic value of clinical laboratory and histological characteristics in multiple myeloma: improved definition of risk groups. Eur. J. Cancer., 1993, 29, 978.
3. Wasseem N.H., Lane D.P: Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA): structural conservation and the detection of a nuclear form. J. Cell Sci., 1990, 96, 121.
4. Hall A., Levison D.A., Woods A.L. et al.: Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J. Pathol., 1990, 162, 285.
5. Giglio A., O'Brien S., Ford R. et al.: Prognostic value of proliferating cell nuclear antigen expression in chronic lymphoid leukemia. Blood, 1992, 79, 2717.
6. Usnarska-Zubkiewicz L.: Cytomorphology and proliferating cell nuclear antigen in myeloma plasma cells correlate with serum IL-6 and sI1-6R concentrations in multiple myeloma. Eur. J. Intern. Med., 1999, 10, 101.
7. Ploton D., Menager M., Jeanesson P, Himber G., Pigeon F.: Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organiser region at the optical level. Histochem. J., 1986, 18, 5.
8. Derenzini M., Pession A., Trere D.: Quantity of nucleolar silver - stained proteins is related to proliferative activity in cancer cells. Lab. Invest., 1990, 63, 137.
9. Durie B.G.M., Salmon S.E.: A clinical staging system for multiple myeloma. Cancer., 1975, 36, 842.
10. Greipp RR., Rymond N.M., Kyle R.A., O'Fallon W.M.: Multiple myeloma significance of plasmablastic subtype in morphological classification. Blood, 1985, 2, 305.
11. Chang C.D., Ottavio L., Travalli S., Lipson K.E., Baserga R.: Transcriptional nuclear antigen gene. Mol. Cell. Biol., 1990, 10, 3289.
12. Ottavio L., Chang C.D., Rizzo M.G., Travalli S., Casadeval C., Baserga R.: Importance of introns in the growth regulation of m-RNA levels of the proliferating cells nuclear antigen gene. Mol. Cell Biol., 1990, 10, 303.
13. Woods A.L., Hall PA., Shepherd N. A., Hanby A.M., Wasseem N.H., Lane D.P, Levison D.A.: The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grades, S +Gs +M phase fraction (flow cytometric analysis) and prognosis. Histopathology, 1991, 18, 21.
14. Jain S., Filipe M., Hall P., Wassem N.H., Lane D.P, Levison D.A.: Prognostic value of proliferating cell nuclear antigen in gastric cancer. J. Clin. Pathol., 1991, 44, 655.
15. Aaltomas S., Lipponen P.M., Syrjanen K.: Prognostic value of cell proliferation in breast cancer as determined by proliferating cell nuclear antigen (PCNA) immunostaining. Anticancer Res., 1992, 12, 1281.
16. Fontatini G., Macchiarini P., Pepe S., Ruggiero A. et al.: The expression of proliferating cell nuclear antigen in paraffin sections of peripheral node-negative non small cell lung cancer. Cancer, 1992, 70, 150.
17. Lipponen P.K., Eskelinen M.J.: Cell proliferation of transitional cell bladder tumours determined by PCNA cyclin immunostaining and its prognostic value. Br. J. Cancer., 1992, 66, 171.
18. Harper M.E., Glynne-Jones E., Goddard W., Wilson D. et al.: Relationship of proliferating cell nuclear antigen (PCNA) in prostatic carcinomas to various clinical parameters. Prostate, 1992, 20, 243.
19. Morita M., Kuwano H., Tsui S., Ohno S., Matsuda H., Sigimachi K.: Cytophotometric DNA content and argyrophilic nucleolar organiser regions of oesophageal carcinoma. Br. J. Cancer., 1993, 67, 480.
20. Mourad W.A., Erkman-Balis B., Livingston S., Shoukri M., Cox C. et al.: Argyrophilic nucleolar organiser regions in breast carcinoma. Correlation with DNA flow cytometry, histopathology and lymph-node status. Cancer, 1992, 69, 1739.
21. Yang P., Huang G.S., Zhu X. S.: Role of nucleolar organiser regions in differentiating malignant from bening tumours of the colon. J. Clin. Pathol., 1990, 43, 235.
22. Lorz M., Meyer Breiting E., Bettinger R.: Proliferating cell nuclear antigen counts as markers of cell proliferating in head neck cancer. Eur. Arch. Otorhinolaryngol., 1994, 251, 2.
23. Pich A., Chiusa L., Marmont F., Navone R.: Risk groups of myeloma patients by histologic pattern and proliferative activity. Am. J. Surg. Pathol., 1997, 21, 339.
24. Skopelitou A., Tselenis S., Theocharis S. et al.: Expression of proliferating cell nuclear antigen (PCNA) and nucleolar organiser regions (NORs) in multiple myeloma. Anticancer Res., 1994, 14, 787.
25. Woźniak Z.M., Usson Y., Parazza F., Champelowier P, Leroux D., Seigneurin D.: Quantitative analysis of three - dimensional distribution of AgNORs proteins during interphase in leukemic cells. Cytometry, 1996, 24, 14.
26. Marmont F., Pich A., Chiusa L. et al.: Correlation between argyrophilic nucleolar organiser region counts and labelling index in multiple myeloma. Eur. J. Haemat., 1996, 56, 39.
27. Usnarska-Zubkiewicz L., Kuliczkowski K.: Prognostic factors and five year survival in patients with plasma cell dyscrasias from Lower Silesia Region. Acta Haematol. Pol., 1998, 29, 443.